JOSE MONTEIRO: Open Payments
NPI 1548203219 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 65 payments from 27 companies in 2025. Trend: 2023 $1,713 · 2024 $1,291 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Novartis Pharmaceuticals Corporation | 8 | $140 |
| PFIZER INC. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Abbott Laboratories | 4 | $77 |
| Novo Nordisk Inc | 3 | $70 |
| Grifols USA, LLC | 3 | $66 |
| Ardelyx, Inc. | 3 | $66 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
Products named: LEQVIO, AIRSUPRA, FREESTYLE LIBRE 3, Rybelsus, Prolastin-C Liquid, IBSRELA, FARXIGA, FANAPT.
Industry payments across MA — which companies pay providers there.
